Home > Financial Ratios > EMCURE PHARMACEUTICALS

EMCURE PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
EMCURE PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for EMCURE PHARMACEUTICALS
Please provide your vote to see the results

EMCURE PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   EV/Core EBITDA(x) 16.6813.551.571.551.40

What is the latest EV/Core EBITDA ratio of EMCURE PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of EMCURE PHARMACEUTICALS is 16.68 based on Mar2026 Consolidated results.
Year EV/Core EBITDA
Mar202616.68
Mar202513.55
Mar20241.57
Mar20231.55
Mar20221.40

How is EV/Core EBITDA of EMCURE PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2026 16.68
23.10
Mar2025 13.55
763.06
Mar2024 1.57
1.29
Mar2023 1.55
10.71
Mar2022 1.4 -

Other Financial Ratios of EMCURE PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of EMCURE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS ₹36,899.5 Cr -2.8% 4.4% 45.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹444,717.0 Cr -0.8% -2.5% 11.9% Stock Analytics
DIVIS LABORATORIES ₹255,115.0 Cr 1.9% 6.6% 55.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹189,613.0 Cr 0.3% 2% 35.9% Stock Analytics
CIPLA ₹112,876.0 Cr 0.9% -0.8% -10.9% Stock Analytics
DR REDDYS LABORATORIES ₹100,395.0 Cr 0.1% 1.4% -9.3% Stock Analytics


EMCURE PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS

-2.8%

4.4%

45.5%

SENSEX

-0.5%

-4.8%

-11%


You may also like the below Video Courses